High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell canal cancer: Final results of a phase II study

Annals of Oncology

Volumn 12, Issue 3, 2001, Pages 397-404

  Peiffert, D ^a   Giovannini, M ^b   Ducreux, M ^c   Michel, P ^d   Francois E ^e   Lemanski, C ^f   Mirabel, X ^g   Cvitkovic, F ^h   Luporsi, E ^a   Conroy, T ^a   Gerard J P ⁱ  

^a CENTRE ALEXIS VAUTRIN   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d HÔPITAL CHARLES NICOLLE   (France)

^e CENTRE ANTOINE LACASSAGNE   (France)

^f CENTRE VAL D AURELLE   (France)

^g CENTRE OSCAR LAMBRET   (France)

^h CENTRE RENÉ HUGUENIN   (France)

ⁱ CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

5 Fluorouracil; Anal cancer; Cisplatin; Phase II study; Radiation therapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANUS CANCER; ANUS SPHINCTER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL TRIAL; COLOSTOMY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; LUNG EMBOLISM; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RECTUM ABDOMINOPERINEAL RESECTION; SKIN DISEASE; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; RADIATION DOSAGE; SALVAGE THERAPY;

EID: 0035072859     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011107105538     Document Type: Article

References (45)

1. Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin
2. Concomitant radio-therapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organisation for Research and Radiotherapy and Gastrointestinal cooperative groups
3. Role of Mitomycin in combination with Fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study
4. Combination of cisplatin plus fluoro-pyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal
5. Epidermoid anal canal carcinoma (EACC): Activity of cisplatin (P) and continuous 5-fluorouracil (5-FU) in metastatic (M) and/or local recurrent (LR) disease
6. Effectiveness of Cisplatin in the treatment of anal squamous-cell carcinoma
7. Cisplatin (P) and 5-fluorouracil (5-FU) for the neoadjuvant treatment (Tt) of epidermoid anal canal carcinoma (EACC)
8. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients
9. Induction chemotherapy plus induction compared with surgery plus radiation in patients with advanced laryngeal cancers
10. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial
11. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial
12. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17
13. Intensification of preoperative chemotherapy for osteogenic sarcoma: Results of the Memorial Sloan-Kettering (T12) protocol
14. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: A study of the European Osteosarcoma Intergroup
15. 0), II, IIIa non-small-cell lung cancer (NSCLC): The French experience
16. Docetaxel (Taxotere) in the neo-adjuvant setting in non-small-cell lung cancer
17. A phase I-II trial of neoadjuvant chemotherapy with cisplatin and vinorelbine followed by accelerated irradiation for patients with inoperable non-small-cell lung carcinoma
18. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: A pilot study and phase III randomized trial
19. Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
20. Actual five-year survival of patients with stage IIIB breast carcinoma: Phase II trial of methotrexate, vinblastine, adriamycin, cisplatin, and folinic acid
21. Induction or neoadjuvant therapy in resectable non-small-cell lung cancer
22. Cisplatin (CDDP) and 5-fluorouracil (5-FU) plus simultaneous radiotherapy (RT) for the treatment of epidermoid carcinoma of the anal region (ECHR)
23. Initial results of a phase II trial of high-dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An Eastern Cooperative Oncology Group Study
24. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: Results in 35 consecutive patients
25. Traitement des carcinomes épidermoïdes du canal anal (CECA) par chimiothérapie (5-FU-CDDP) et radiothérapie concomitante. Résultats chez 15 patients
26. Chemoradiation therapy for anal cancer: Radiation plus continuous infusion of 5-fluorouracil with or without cisplatin
27. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C
28. Epidermoid carcinoma of the anal canal. A series of 276 cases
29. Preliminary results of a phase II study of a high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: A French cooperative study
30. Non parametric estimation from incomplete observation
31. Primary systemic therapy in operable breast cancer
32. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: A seven-year assessment of a randomized controlled trial
33. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
34. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer
35. Induction chemotherapy and radiotherapy in loco-regionally advanced epidermoid carcinoma of the anal canal
36. Combined-Modality therapy of poor risk anal canal carcinoma: A phase II study of the Cancer and Leukemia Group B (CALGB)
37. Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumoral control and complications
38. Treatment of squamous cell anal canal carcinoma with pulsed dose rate brachytherapy
39. Carcinoma of the anal canal
40. 3 anal carcinomas treated by radiation with or without chemotherapy
41. Dose-time considerations in the treatment of anal cancer
42. Dose escalation in chemoradiation for anal cancer: Preliminary results of RTOG 92-08
43. Dose escalation without split-course chemoradiation for anal cancer: Results of a phase II RTOG study